KFDA approves once a day dose of Sprycel

Published: 2011-04-20 06:56:00

Updated: 2011-04-20 06:56:00

The Korea Food and Drug Administration has recently granted once a day dose of Bristol-Myers Squibb (BMS)’s Sprycel (dasatinib) 100 mg in addition to Sprycel 50 mg (twice a day).

“Many patients who were resistant or intolerant to Gleevec may respond to a once a day dose of Sprycel with an impr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK